Cambridge Investment Research Advisors’s Cardiol Therapeutics CRDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $280K | Sell |
206,265
-115,020
| -36% | -$156K | ﹤0.01% | 3040 |
|
|
2025
Q1 | $310K | Sell |
321,285
-9,220
| -3% | -$8.9K | ﹤0.01% | 2840 |
|
|
2024
Q4 | $424K | Buy |
330,505
+269,504
| +442% | +$346K | ﹤0.01% | 2563 |
|
|
2024
Q3 | $121K | Sell |
61,001
-55,130
| -47% | -$109K | ﹤0.01% | 3237 |
|
|
2024
Q2 | $235K | Sell |
116,131
-12,612
| -10% | -$25.5K | ﹤0.01% | 2904 |
|
|
2024
Q1 | $233K | Buy |
128,743
+43,542
| +51% | +$78.8K | ﹤0.01% | 2896 |
|
|
2023
Q4 | $72K | Hold |
85,201
| – | – | ﹤0.01% | 3071 |
|
|
2023
Q3 | $76K | Buy |
85,201
+8,590
| +11% | +$7.66K | ﹤0.01% | 3000 |
|
|
2023
Q2 | $68K | Buy |
76,611
+30,600
| +67% | +$27.2K | ﹤0.01% | 3053 |
|
|
2023
Q1 | $22K | Buy |
+46,011
| New | +$22K | ﹤0.01% | 3097 |
|